Welcome to LookChem.com Sign In|Join Free
  • or
2-Bromo-4,5-difluoronitrobenzene is a chemical compound with the molecular formula C6H3BrF2NO2. It is a nitrobenzene derivative that contains bromine, fluorine, and nitro groups attached to a benzene ring. 2-Bromo-4,5-difluoronitrobenzene is known for its reactivity and potential hazards, necessitating careful handling and safety measures during its use.

321-17-5

Post Buying Request

321-17-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

321-17-5 Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-4,5-difluoronitrobenzene is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-4,5-difluoronitrobenzene serves as an intermediate for the production of pesticides and other agrochemicals, contributing to the development of effective solutions for crop protection and management.
Used in Dye Industry:
2-Bromo-4,5-difluoronitrobenzene is utilized as an intermediate in the synthesis of dyes, enabling the creation of a wide range of colorants for various applications, including textiles, plastics, and printing inks.
Used in Organic Electronic Devices and Materials:
2-Bromo-4,5-difluoronitrobenzene has been studied for its potential application in organic electronic devices and materials, such as organic light-emitting diodes (OLEDs) and organic solar cells, due to its electronic and optical properties.

Check Digit Verification of cas no

The CAS Registry Mumber 321-17-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,2 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 321-17:
(5*3)+(4*2)+(3*1)+(2*1)+(1*7)=35
35 % 10 = 5
So 321-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H2BrF2NO2/c7-3-1-4(8)5(9)2-6(3)10(11)12/h1-2H

321-17-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-bromo-4,5-difluoro-2-nitrobenzene

1.2 Other means of identification

Product number -
Other names 2-Brom-4.5-difluornitrobenzol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:321-17-5 SDS

321-17-5Relevant academic research and scientific papers

Carbazole derivative, material for organic electroluminescent element which comprises same, and organic electroluminescent element and electronic device each manufactured using same

-

Paragraph 0255; 0256, (2016/11/21)

Provided are: a carbazole derivative represented by formula (1), which is a novel material useful as a material for an organic electroluminescent element, and in which each of at least two specific structural groups typified by carbazole are bound to any

N-(2-ARYLETHYL) BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR

-

Paragraph 0194, (2016/01/25)

The present invention relates to the use compounds of formula I which are antagonists of the 5-HT 6 receptor, for treating a cognitive disorder selected from the group consisting of age-related cognitive decline, mild cognitive impairment and dementia

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

-

Page/Page column 67, (2014/09/29)

The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

-

Page/Page column 65; 66, (2014/09/29)

Disclosed are indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which LRRK2 kinase is involved. Also disclosed are pharmaceutical compositions in the prevention or treatment of such diseases in which LRRK2 kinase is involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 321-17-5